UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014421
Receipt number R000016780
Scientific Title Prospective cohort study for gastroenteropancreatic neuroendocrine tumor
Date of disclosure of the study information 2014/06/30
Last modified on 2014/06/30 12:12:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective cohort study for gastroenteropancreatic neuroendocrine tumor

Acronym

Prospective cohort study for GEP-NET

Scientific Title

Prospective cohort study for gastroenteropancreatic neuroendocrine tumor

Scientific Title:Acronym

Prospective cohort study for GEP-NET

Region

Japan


Condition

Condition

gastroenteropancreatic neuroendocrine tumor

Classification by specialty

Gastroenterology Hepato-biliary-pancreatic medicine Gastrointestinal surgery
Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The objective of this study is to accumulate prospectively the clinical feature of the patients who was treated with gastroentero-pancreatic neuroendocrine tumor.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

disease free survival

Key secondary outcomes

overall survival


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

All the patients who treated with gastroenteropancreatic neuroendocrine tumor in the participating institutes

Key exclusion criteria

N/A

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Michiaki Unno

Organization

Tohoku University Hospital

Division name

Hepato-Biliary Pancreatic surgery

Zip code


Address

1-1 Seiryo-cho, Aoba-ku, Sendai, 980-8574, Japan

TEL

022-717-7205

Email

m_unno@surg1.med.tohoku.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takeshi Aoki

Organization

Tohoku University Hospital

Division name

Hepato-Biliary Pancreatic surgery

Zip code


Address

1-1 Seiryo-cho, Aoba-ku, Sendai, 980-8574, Japan

TEL

022-717-7205

Homepage URL

http://www.surg1.med.tohoku.ac.jp/

Email

takegogo13@gmail.com


Sponsor or person

Institute

Departent of Surgery, Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Tohoku University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

仙台オープン病院(宮城県)、仙台厚生病院(宮城県)、山形県立中央病院(山形県)、仙台医療センター(宮城県)、東北労災病院(宮城県)、宮城県南中核病院(宮城県)、JCHO仙台南病院(宮城県)、東北薬科大学病院(宮城県)、十和田市立中央病院(青森県)、塩竈市立病院(宮城県)、仙台徳洲会病院(宮城県)、白河厚生総合病院(福島県)、宮城県立がんセンター(宮城県)、いわき市立総合磐城共立病院(福島県)仙北組合総合病院(秋田県)


Other administrative information

Date of disclosure of the study information

2014 Year 06 Month 30 Day


Related information

URL releasing protocol

http://www.surg1.med.tohoku.ac.jp/

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2014 Year 05 Month 31 Day

Date of IRB


Anticipated trial start date

2014 Year 06 Month 30 Day

Last follow-up date

2019 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Primary lesion
Treatment (Operation)
pathological diagnosis
recurrence or not
disease free survival
treatment for the recurrence
Overall survival


Management information

Registered date

2014 Year 06 Month 30 Day

Last modified on

2014 Year 06 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016780


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name